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Abstract 
Endocan is a dermatan sulfate proteoglycan
(DSPG) that has been observed in the cyto-
plasm of endothelial cells of small and large
vessels in lung, kidney, liver, colon, ovary and
brain tumors. This DSPG has been implicated
in the regulation of cellular activities such as
adhesion, migration, and proliferation. Given
the important roles played by endocan in such
processes,  we  sought  to  determine  whether
this DSPG is present in the chicken embryo
aortic wall in embryonic days 12 and 14, when
intimal  thickening  and  endothelial  transfor-
mation are notorious. Immunolabeling of seri-
al  paraffin  cross-sections  revealed  endocan
immunoreactivity  at  the  endothelium  and
some mesenchymal cells constituting the inti-
mal thickening but not in the cells arranged in
lamellar layers. We also investigated whether
endocan was present in monolayers of primary
embryonic aortic endothelial cells attached to
fibronectin when they were deprived of serum
and stimulated with epidermal growth factor.
Immunofluorescence  determined  that  in  the
epidermal  growth  factor  (EGF)  condition
where  separating,  detaching,  and  migrating
cells were observed, endocan appeared organ-
ized in arrays typical of focal complexes in the
leading  edge  of  these  cells.  In  serum-free
medium  condition  in  which  the  endothelial
cells  displayed  a  cobblestone  appearance,
endocan appeared mainly delineating the mar-
gin of many cells. This study demonstrates for
the first time the presence of endocan during
the aortic wall remodeling, and provides evi-
dence that suggests a possible contribution of
this  DSPG  in  the  endothelial-mesenchymal
transition (EndoMT) process. 
Introduction
Endothelial-mesenchymal  transition
(EndoMT) is a complex process by which cer-
tain endothelial cell subsets lose endothelial
characteristics and transform into mesenchy-
mal  or  smooth  muscle  cells  (SMCs).1 This
process is now recognized as a phenomenon
that occurs during cardiac fibrosis2 and neoin-
timal thickening formation observed in ather-
osclerosis and restenosis.1,3 In addition to this
role,  recent  evidence  has  also  demonstrated
that EndoMT is critical in heart and vascular
development,1,4 hypertrophic scarring,5 kidney
fibrosis,6 diabetic  nephropathy7 and  during
cancer progression.8 EndoMT process entails
growth  factor  and  cytokines  synthesis  and
secretion,  activation  of  receptor  tyrosine
kinases  (RTKs)  and  non-RTKs,  cytoskeleton
reorganization, disassembly of the adherence
junctions or loss of endothelial cell-cell con-
tacts, change in cell shape and polarity, pro-
teases secretion, extracellular matrix (ECM)
remodeling,  cell  separation  or  detachment
from the substratum, and cell migration and
differentiation.1,9
In addition to permanent interaction with
other cells, endothelial cells also need to inter-
act with the ECM. It is now well established
that most ECM molecules participate in tissue
remodeling by promoting cell adhesion provok-
ing cytoskeletal organization, and regulating
cell  spreading,  polarization,  detachment,
migration and differentiation in response to
mechanical stimuli and/or cross talk of a vari-
ety of growth factors and cytokines.10 Some of
the most studied ECM molecules in the vessel
wall  belong  to  the  family  of  proteoglycans
(PGs), which are actually recognized by its role
in several cellular processes either via interac-
tions with ECM receptors like integrins or via
signaling  through  receptor  tyrosine  kinases
(RTKs).11 Some particularly significant studies
on  the  developing  of  chick  aorta  show  that
large PGs containing EGF-like domains such as
versican and aggrecan have different spatial
and temporal expression patterns, suggesting
a possible role for these molecules during inti-
mal thickening formation and EndoMT.11,12
Endocan, also called endothelial cell-specific
molecule-1, is a small dermatan sulfate proteo-
glycan (DSPG) that does not seem to belong to
the small leucine-rich PGs (SLRPG) family and
is mainly expressed by endothelial cells and
regulated  in  vivo  by  inflammatory  cytokines
such  as  vascular  endothelial  growth  factor
(VEGF), fibroblast growth factor-2 (FGF-2), and
tumor  necrosis  factor-α (TNF-α).13-16 This
DSPG consist of a core protein that contains an
N-terminal rich in cysteine residues, a puta-
tive EGF-like domain, whose functional signif-
icance is not yet fully understood, and a single
chain of dermatan sulfate (DS), which is cova-
lently linked to the core protein.15Interestingly,
a  marked  expression  of  endocan  has  been
observed in breast, brain, lung, liver, kidney,
ovary  tumors,  thus  suggesting  an  important
role  of  endocan  in  angiogenesis  and  in  the
development  and  progression  of  cancer.16
Nevertheless, the factors regulating the syn-
thesis and secretion as well as their functions,
have not yet been fully elucidated. 
In view of the above observations, the aim of
this  study  was  to  investigate  immunohisto-
chemically whether endocan is present in the
chicken embryo aortic wall in embryonic days
12 and 14 (days E12 and E14; stages 38 and
40), when intimal thickening and endothelial
transformation are notorious. We also investi-
gated the presence of endocan in monolayers
of primary embryonic aortic endothelial cells
attached  to  fibronectin  (FN)  and  stimulated
with epidermal growth factor (EGF).
Materials and Methods
Tissue extraction
Fertilized  chicken  eggs  (White  leghorn)
were obtained from a local hatchery (Granja
Avícola  Agropollito  C.A.,  Paracotos,  Estado
Miranda, Venezuela) and incubated at 37ºC and
60% humidity for 12 and 14 days (stages 38 and
40).  Embryos  were  staged  according  to
Hamburger  and  Hamilton.17 The  aortae  were
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dissected were placed in Hank’s balanced salt
solution  without  Ca++ and  Mg++ (HBSS)
(Sigma-Aldrich, St. Louis, MO, USA), and fixed
for  15  min  at  room  temperature  with  4%
formaldehyde prepared from paraformaldehyde
in phosphate-buffered saline (PBS). The aortae
were dehydrated in graded ethanol and embed-
ded in paraffin. Paraffin sections (5 μm thick)
were mounted on silanized slides (Dako, Inc.,
Carpinteria, Ca, USA). A total of two aortae for
each stage obtained from three different lots of
fertilized chicken eggs were processed. 
Indirect immunofluorescence
Serial deparaffinized cross sections were air
dried and equilibrated in PBS for 10 min. Non-
specific antibody staining was blocked by incu-
bating sections in PBS containing 2% bovine
serum albumin (BSA) for 30 min at room tem-
perature. Sections were incubated overnight at
4ºC in a humid chamber with mouse mono-
clonal  anti-human  endocan/ESM-1  antibody
(clone MEP08) (Lunginnov, Lille, France) or
mouse monoclonal antibody anti α-SM actin
(clone  1A4)  (Sigma-Aldrich).  After  the  sec-
tions were washed several times in PBS, anti-
mouse  FITC-conjugated  secondary  antibody
(Dako) was applied for 30 min. The sections
were again washed in PBS, and coverslipped
with  mounting  medium  (IMMU-mount;
Shandon, Pittsburg, PA, USA). Negative con-
trols were produced by the use of purified nor-
mal serum or PBS in place of primary antibody.
A IX81 Olympus inverted microscope with the
Fluo-View confocal laser scanning configura-
tion (CLSM) (Olympus America, Inc., Melville,
NY, USA) was used to examine the sections.
Fluorescence intensity was measured by using
a  processing  software  program  (FV10.  ASW
version 02.01.01.04, Olympus Corporation).
Cell cultures
Aortae from days E11-E12 (stages 37 and 38)
were  dissected  in  HBSS  (Sigma-Aldrich)  at
37ºC. Segments, approximately 8 mm2 in sur-
face area, were isolated (distal to the aortic
arches)  and  opened  along  longitudinal  axis.
Explants were rinsed in HBSS (Sigma-Aldrich)
and left in medium 199 with Earle’s salts with
L-Glutamine  (Sigma-Aldrich)  containing
0.025% BSA (Sigma-Aldrich), 100 μg/mL strep-
tomycin,  and  100  U/mL  penicillin  (GIBCO,
Invitrogen, Carlsbad, CA, USA) for 5-10 min
before starting the assays. For simplicity, this
medium is referred to as serum-free medium
(SFM). Aortic explants were placed with the
endothelial  apical  side  down  on  fibronectin-
coated 35 mm Petri dishes (Nunclon, Delta, IL,
USA) containing 300 μL of SFM. They were
incubated at 37ºC in a humidified atmosphere
consisting of 5% C02 and 95% air for 4 h. After
this interval, 1 mL of SFM was gently added to
each dish. Two h later, the adhered explants
were removed with the aid of a thin needle,
leaving a monolayer of retracted endothelial
cells that exhibited zones denuded of cells or
wounds. Monolayers were examined with an
inverted microscope (IX-70 Olympus, Olympus
America  Inc.).  Cell  cultures  were  initiated
when the monolayers of endothelial cells were
rinsed 5 times with HBSS and incubated for 2
h at 37ºC with 5% CO2. At the end of this time,
the medium of the monolayers was switched to
SFM supplemented with recombinant epider-
mal growth factor (EGF) (R&D Systems, Inc.,
Minneapolis, MN, USA) (100 ηg/mL) and 0.1%
chicken serum (ChS) (GIBCO) and incubated
for an additional 10-12 h period.
Indirect immunofluorescence
Fixed  and  permeabilized  cells  were
processed  for  immunostaining  as  described
above using the following antibodies: a mouse
monoclonal  anti-human  endocan/ESM-1
(clone MEP08) (Lunginnov), a rabbit polyclon-
al anti-human von Willebrand´s factor (vWf)
(Dako), a mouse monoclonal antibody raised
against native chick brain microtubules (clone
DM1A) (Santa Cruz Biotechnology Inc., Santa
Cruz, CA, USA), a mouse monoclonal antibody
anti-human β3-integrin (GPIIIa, CD61) (clone
25E11)  (Millipore  Chemicon  Corporation,
Billerica,  MA,  USA),  and  a  rabbit  polyclonal
anti-phospho-FAK  (Tyr-397)  (Sigma-Aldrich).
Negative controls were performed by omitting
the  primary  antibody  incubation  step  or  by
using non-immune serum instead of primary
antibody. A confocal laser scanning microscope
(CLSM) (Eclipse TE-300 Nikon inverted micro-
scope) (Nikon Instruments Inc., Melville, NY,
USA) equipped with a Nikon objective Plan-
Apo BC x60, 1.2 wi coupled to a C1-LU2 unit
Argon cooled air (488 ηm) laser was used to
examine the cultures. The laser unit was con-
trolled by a D-eclipse C1 interface.
Brief Note
Figure 1. Overlay of transmission and red or green fluorescence images of serial paraffin
cross sections of chicken embryo aorta at day E12 of development immunolabeled with
either anti-αSM actin or anti-endocan antibodies. In this stage, it is possible to distin-
guish mesenchymal cells (mc) adjacent to the endothelium (e) forming an intimal thick-
ening (IT). Strong α-SM actin immunoreactivity is detected in few mesenchymal cells
(mc) and in the cells arranged in lamellar layers (lc) but not in interlamellar cell layers
(ilc). Strong endocan immunoreactivity is detected in the endothelium (e) as well as in
some adjacent mesenchymal cells (mc). Histograms represent the percentage of fluores-
cence intensity for α-SM actin (red) and endocan (green) after setting the ROI on the
superimposed images.[European Journal of Histochemistry 2011; 55:e13] [page 75]
Results
In vivo immunolocalization 
of endocan
In order to investigate the expression and
localization of endocan in the aortic wall at
days E12 and E14 (stages 38 and 40) of devel-
opment  when  intimal  thickening  is  distin-
guishable and EndoMT occurs,18 serial paraffin
sections  were  examined  by  confocal
microscopy.  A  specific  monoclonal  antibody
that recognizes epitopes on the N-terminus of
endocan was used.
At 12-14 days of development, the aortic wall
is composed by the endothelium, which limits
the vessel lumen, and radially oriented mes-
enchymal cells originating from the endotheli-
um and that constitute the intimal thickening.
At these stages it is also possible to distinguish
cells organized into circular lamellar and inter-
lamellar  layers  that  form  the  media.
Occasionally,  some  mesenchymal  cells  and
lamellar  cell  layers  are  observed  displaying
immunoreactivity for α-smooth muscle actin
(α-SM  actin)  (Figure  1).  At  these  stages,  a
strong  immunoreactivity  for  endocan  was
found at the endothelium and some mesenchy-
mal cells constituting the intimal thickening
but not in the cells arranged in lamellar layers
(Figure 1).
No immunoreactivity was detected when the
primary antibody was omitted or replaced by
non-immune  serum  in  control  sections  (not
shown).
In vitro immunolocalization 
of endocan
Based on our findings in vivo, we also inves-
tigated whether endocan was present in mono-
layers of embryonic endothelial cells attached
to FN that had been transiently mechanically
altered during the explant removal, when they
were deprived of serum for 2 h and switched to
medium supplemented with EGF and ChS and
maintained for an additional 10 or 12 h period.
Immunofluorescence  analyzed  by  confocal
microscopy determined that in the EGF condi-
tion  in  which  separating,  detaching,  and
migrating endothelial cells are observed and
the vWf expression is notorious (Figure 2 a,b),
all of the cells displayed strong immunoreactiv-
ity for endocan (Figure 2 c,d). Specifically, this
DSPG in addition to being located delineating
the margins of some endothelial cells, was also
located in punctate and linear arrays typical of
focal complexes at the leading edge as well as
in  the  area  surrounding  the  microtubule-
organizing center (MTOC) and aligned with
microtubules (MTs) of separating, detaching,
and migrating cells (compare panels c and e in
Figure 2). Focal adhesion complexes are con-
sidered  not  only  as  structural  and  dynamic
links between the ECM and the cytoskeleton
controlling cell shape, spreading and motility,
but  also  as  sites  for  signal  transduction
through integrins and adaptor proteins such as
focal adhesion kinase (FAK) and paxillin that
are present in these sites. We therefore stud-
ied  the  presence,  organization  and  distribu-
tion of these proteins by confocal microscopy
in monolayers of embryonic endothelial cells
attached to FN and stimulated with EGF for 10-
12 h. In such condition, immunofluorescence
staining with anti-integrin-β3 and anti-p-FAK
revealed that many cells displayed immunore-
activity with a location and distribution resem-
bling to that observed for endocan. Specifically,
integrin-β3 and  p-FAK  appeared  delineating
the margins of some cells and organized into
linear streaks and a punctate pattern at the
leading edge of the cells that were separating,
detaching, and migrating (Figure 3 a,b). In the
SFM condition in which the endothelial cells
displayed a cobblestone appearance and nei-
ther separating, detaching nor migrating cells
were observed, endocan, integrin-β3 and p-FAK
Brief Note
Figure 2. Representative CLSM fluorescence images of vWf, endocan, and tubulin in
monolayers of endothelial cells attached to FN after 10 h in culture in the presence of
EGF. a) Strong immunoreactivity for vWf in a punctate and granular pattern typical of
endothelial cells is observed in separating, detaching, and migrating cells. b) High mag-
nification of vWf clustering around the nucleus of separating cells and disperse in the
leading edge of migrating cells. c) Strong immunoreactivity for endocan is observed at
the plasma membrane as well as in the leading edge and in the area surrounding the
MTOC and aligned with MTs. d) Shows at high magnification the punctate and linear
arrays of endocan. e) Tubulin immunoreactivity is observed surrounding the MTOC and
in the MTs radially distributed along the cytoplasm. a), c), e) scale bars = 25 µm; b) and
d) scale bars = 10 µm.[page 76] [European Journal of Histochemistry 2011; 55:e13]
appeared  mainly  distributed  delineating  the
margins of many cells (Figure 4 a,b,c). 
No immunolabeling was observed when a
non-immune serum was used as negative con-
trol (not shown).
Discussion
The current study reveals the existence of
both endocan-immunoreactive endothelial and
mesenchymal cells in the intimal thickenings
observed in chicken embryo aortae on days E12
and E14. This study also provides evidence that
allow us to suggest a possible contribution of
this DSPG in the EndoMT process.
Endocan is a DSPG expressed specifically by
endothelial cells and has been implicated in
several pathophysiological processes as well as
in the regulation of cellular activities such as
adhesion, migration and proliferation.14,16 By
immunohistochemistry,  endocan  has  been
observed in the cytoplasm of endothelial cells
of small and large vessels in lung, kidney, liver,
colon, ovary and brain tumors.16 Thus, it is of
interest  that  a  strong  endocan  staining  was
detected in the endothelium and some migrat-
ing mesenchymal cells that conform the spon-
taneous intimal thickening but not in those
cells organized in lamellar layers. This implies
that  endocan  would  be  participating  in  the
EndoMT and therefore contributing to the aor-
tic wall remodeling. Importantly, spontaneous
aortic and pulmonary intimal thickenings have
been  demonstrated  during  chicken  embryo
development  and  related  to  blood  pressure
alterations that occur rapid and exponentially
from day E3 to day E10 of development accom-
panied by the local production and activation of
different growth factors such as FGF-2, TGFβ
and IGFII.19,20 It might thus be speculated that
the presence of endocan in the embryonic aor-
tic wall would occur in response to hemody-
namic  changes  and  production  of  certain
growth  factors,  considering  that  endocan
expression,  synthesis  or  secretion  is  highly
regulated  by  VEGF  and  FGF-2,14,16 and  that
TGFβstimulates the synthesis and secretion of
the  core  protein  of  some  PGs.21,22 Also,  this
presence  may  be  interpreted  as  a  sign  of
endothelial activation.
In this study, we also found that the spatial
distribution  and  organization  of  endocan
observed in SFM condition was altered when
the  monolayers  were  stimulated  with  EGF.
Specifically, endocan appeared delineating the
margins of cells in arrays typical of focal com-
plexes  in  the  leading  edges  as  well  as  sur-
rounding the MTOC and aligned with MTs of
the cells that were separating, detaching and
migrating toward cell-free areas. We believe
that  this  peculiar  localization  of  endocan
Brief Note
Figure 4. Representative CLSM fluorescence images of endocan, integrin-β3 and p-FAK
in monolayers attached to FN after 10 h in culture in SFM. a) and b) Endocan and inte-
grin-β3  are  seen    delineating  the  margin  of  many  cells  that  displayed  a  cobblestone
appearance. c) p-FAK is seen delineating the margin of cells and organized into linear
streaks, typical of focal adhesions. a), b) scale bars = 25 µm; c) scale bar = 50 µm.
Figure 3. Representative CLSM fluorescence images of integrin-β3 and p-FAK in monolay-
ers of endothelial cells attached to FN after 10 hr in culture in the presence of EGF. a)
Integrin-β3 is seen delineating the margin of some cells and organized into linear streaks
and a punctate pattern at the leading edge of the migrating cells. b) p-FAK is seen at the lead-
ing edge in arrays typical of focal complexes. a) Scale bar = 25 µm. b) scale bar = 10 µm.[European Journal of Histochemistry 2011; 55:e13] [page 77]
would  be  linked  with  a  participation  in  the
assembly, disassembly, and signaling of focal
adhesions,  in  which  integrin-β3 clustering
induced by FN and activation of adaptor pro-
teins, including focal adhesion kinase (FAK)
and paxillin that interact with cytoskeletal pro-
teins such as microtubules and actin microfil-
aments, are required.23-27 Moreover, consider-
ing that inmunoreactivities observed for inte-
grin-β3and p-FAK in separating, detaching and
migrating cells, resembled to that observed for
endocan.  
As suggested, the function of DS-chain of
endocan is to bind some growth factors and
cytokines as well as ECM molecules including
FN  and  collagen,  but  the  functional  signifi-
cance  of  its  EGF-like  is  not  yet  fully  under-
stood.15 It is likely that endocan, through its
EGF-like domain, directly binds to integrin-β3,
a cell surface receptor that is present on the
apical side of endothelial cells,28,29and that this
binding  occurs  in  the  presence  of  divalent
cations,  considering  that  endocan  interacts
physically and functionally with the integrin
lymphocyte  function  associated-antigen-1
(LFA-1), present in leukocyte and Jurkat cells,
through its polypeptide moiety13 and that the
binding of growth factors containing EGF-like
motifs to integrin α5β3 occurs via its EGF-like
motif.30 Also,  it  is  possible  that  endocan
through its DS-chain binds to FN, facilitating
the endothelial cell adhesion. Based on these
asseverations and our findings, we hypothe-
sized that endocan might be cooperating with
integrins to promote focal complexes assembly
and  disassembly  and  hence  influencing  cell
separation, detachment and migration, impor-
tant steps for the EndoMT.  
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